Improved anti-TNFR1 polypeptides, antibody variable domains & antagonists

Details for Australian Patent Application No. 2010215479 (hide)

Owner Glaxo Group Limited

Inventors Duffield, Stephen; Enever, Carolyn; Liu, Haiqun; Schon, Oliver; Sepp, Armin; Stoop, Allart Adriaan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010215479

PCT Pub. Number WO2010/094720

Priority 61/153,746 19.02.09 US; 61/241,198 10.09.09 US

Filing date 17 February 2010

Wipo publication date 26 August 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/44 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies bound to carriers

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/094720 Priority application(s): WO2010/094720

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010215481-Improved anti-serum albumin binding variants

2010215469-Low delay modulated filter bank